| Innovative Pulmonary & PEGylation-based Therapeutic Product ...
Innovative pulmonary and PEGylation-based therapeutic product development is the focus of two new business units recently created at Nektar Therapeutics (Nasdaq: NKTR), the company announced recently. Nektar also announced the creation of a new global communications team to expand and fortify investor and analyst relations.
"We have focused our strongest leaders on our core technologies to accelerate the development of breakthrough pulmonary and PEGylation-based therapeutics to help patient and medical professionals," said Nektar President and Chief Executive Officer Howard W. Robin. "And we have hired two experienced communications professionals, who have strong ties with the investment, analyst, medical and media communities, which will not only improve transparency with these stakeholders but also enable us to better articulate our value proposition and corporate developments."
Nektar PEGylation Platform
Nektar PEGylation technology can enhance the properties of therapeutic agents by increasing drug circulation time in the bloodstream, decreasing immunogenicity and dosing frequency, increasing bioavailability and improving drug solubility and stability.
Volunteer opportunities for April 29
The Juvenile Diabetes Research Foundation: Volunteers are needed at the Walk to Cure Diabetes on May 19 at Riverside Park, Neenah. Volunteers are needed for setup, registration, lunch, cleanup and other duties. Contact: Patty, 920-735-6556. The Fox Cities Victim Crisis Response Team: Concerned community members who have the desire to assist people in crisis are needed. Volunteers will attend a 20-hour training session that covers crisis intervention, trauma, community referrals, the criminal justice system and more. The next training session will be 6-10 p.m. May 16 and 18 and 9-4 p.m. May 19 and 11 a.m.-5 p.m. May 20. All training will be held at the Menasha Police Department, 430 First Street, Menasha. Contact: Barb Bigalke, 920-967-5150 or bbigalke@ci.menasha.wi.us. Pals Program: An 8-year-old Appleton girl would like a mentor to take her to parks, community events or just hang out baking, biking or making crafts.
Abbott's motto - Turning Science into Scaring - AIDS Healthcare ...
AIDS (Acquired Immunodeficiency Syndrome or Acquired Immune Deficiency Syndrome, sometimes written Aids) is a human disease characterized by progressive destruction of the body's immune system. It is widely accepted that AIDS results from infection with HIV (Human Immunodeficiency Virus). .
Nutraceutical Reports Q2 Results
PARK CITY, Utah, April 26 /PRNewswire-FirstCall/ -- Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2007 second quarter ended March 31, 2007. Net sales for the fiscal 2007 second quarter were $42.1 million compared to $41.0 million for the same quarter of fiscal 2006. For the second quarter, net income was $4.2 million, or $0.37 diluted earnings per share, compared to net income of $5.0 million ($4.3 million excluding a $0.7 million gain from a building sale), or $0.43 diluted earnings per share ($0.37 excluding $0.06 per share from a building sale), for the same quarter of fiscal 2006. Net sales for the six months ended March 31, 2007 were $78.0 million compared to $77.7 million for the same period in fiscal 2006. For the six months ended March 31, 2007, net income was $7.5 million, or $0.67 diluted earnings per share, compared to $8.5 million ($7.8 million excluding a $0.7 million gain from a building sale), or $0.73 ($0.67 excluding $0.06 per share from a building sale), for the same period of fiscal 2006.
|
